Relation of Body Mass Index to Outcomes in Acute Coronary Syndrome.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 05 07 2020
revised: 24 09 2020
accepted: 30 09 2020
pubmed: 16 10 2020
medline: 2 2 2021
entrez: 15 10 2020
Statut: ppublish

Résumé

We assessed the association of BMI with all-cause and cardiovascular (CV) mortality in a contemporary acute coronary syndrome cohort. Patients from the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events and Global Registry of Acute Coronary Events between 2009 and 2019, were divided into BMI subgroups (underweight: <18.5, healthy: 18.5 to 24.9, overweight: 25 to 29.9, obese: 30 to 39.9, extremely obese: >40). Logistic regression was used to determine the association between BMI group and outcomes of all cause and CV death in hospital, and at 6 months. 8,503 patients were identified, mean age 64 ± 13, 72% male. The BMI breakdown was: underweight- 95, healthy- 2,140, overweight- 3,258, obese- 2,653, extremely obese- 357. Obese patients were younger (66 ± 12 vs 67 ± 13), with more hypertension, diabetes, and dyslipidemia vs healthy (all p < 0.05). Obese had lower hospital mortality than healthy: all-cause: 1% versus 4%, aOR (95% CI): 0.49(0.27, 0.87); CV: 1% versus 3%, 0.51(0.27, 0.96). At 6-month underweight had higher mortality than healthy: all-cause: 11% versus 4%, 2.69(1.26, 5.76); CV: 7% versus 1%, 3.54(1.19, 10.54); whereas obese had lower mortality: all-cause: 1% versus 4%, 0.48(0.29, 0.77); CV: 0.4% versus 1%, 0.42(0.19, 0.93). When BMI was plotted as a continuous variable against outcome a U-shaped relationship was demonstrated, with highest event rates in the most obese (>60). In conclusion, BMI is associated with mortality following an acute coronary syndrome. Obese patients had the best outcomes, suggesting persistence of the obesity paradox. However, there was a threshold effect, and favorable outcomes did not extend to the most obese.

Identifiants

pubmed: 33058799
pii: S0002-9149(20)31094-8
doi: 10.1016/j.amjcard.2020.09.059
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-19

Informations de copyright

Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Auteurs

Seshika Ratwatte (S)

Department of Cardiology, Concord Repatriation General Hospital, Concord, Australia.

Karice Hyun (K)

ANZAC Research Institute, NSW, Australia; Westmead Applied Research Centre, University of Sydney, NSW, Australia.

Mario D'Souza (M)

University of Sydney, NSW, Australia; Clinical Research Centre, Sydney Local Health District, NSW, Australia.

Jennifer Barraclough (J)

University of Sydney, NSW, Australia.

Derek P Chew (DP)

Department of Cardiology, Flinders University, Australia.

Pratap Shetty (P)

Department of Cardiology Wollongong Hospital, NSW, Australia.

Sanjay Patel (S)

Department of Cardiology Royal Prince Alfred Hospital, NSW, Australia.

David Amos (D)

Department of Cardiology, Orange Base Hospital, NSW, Australia.

David Brieger (D)

Department of Cardiology, Concord Repatriation General Hospital, Concord, Australia. Electronic address: david.brieger@health.nsw.gov.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH